Impact of Minimal Residual Disease Detection by Next Generation Flow Cytometry on Outcome of Egyptian Patients with Acute Lymphoblastic Leukemia

Recently, the identification of minimal residual disease (MRD) that persists after chemotherapy has emerged as the most powerful tool in determining the prognosis of patients with acute lymphoblastic leukemia (ALL). Multiple methods to detect MRD exist, each with its own benefits and drawback. Multi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Asian Pacific Journal of Cancer Prevention 2023-10, Vol.24 (10), p.3577-3584
Hauptverfasser:	Algamal, Reem Ahmed, Abu Samra, Nashwa Khairt, Ellashery, Rasha Abd-elmalk, Abd-EL-Hameed, Suzy Abd Elamabood, Shahin, Doaa Abdelhalim
Format:	Artikel
Sprache:	eng
Schlagworte:	Egypt - epidemiology Flow Cytometry - methods Humans Neoplasm, Residual - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Prognosis Recurrence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!